Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death,… read more.
Report from the ACC Annual Scientific Meeting, 29 – 31 March 2014 in Washington. Angiotensin-converting-enzyme (ACE) inhibitors are associated with reduced mortality and cardiovascular events in patients… read more.
Maria Dalby reporting on the Oral Presentation by Mari Kilner, Freeman Hospital, Newcastle upon Tyne- Thromboelastography is a method of testing the efficiency of coagulation which measures not… read more.
Maria Dalby reporting on the Oral Presentation by Phanibhushana Munipalle, Southmead Hospital, Bristol. Altruistic organ donation, that is, where a person volunteers to donate a kidney for transplantation… read more.
by Bruce Sylvester – A traditional Chinese herbal medication appears to slow progression from pre-diabetes to diabetes, and at a rate similar to prescription treatments, researchers reported in… read more.
Evidence increasingly suggests that insufficient or disturbed sleep is associated with metabolic disorders such as type 2 diabetes and obesity, and addressing poor quality sleep should be a… read more.
by Gary Finnegan: New research reveals that patients in Sweden have a better chance of surviving a heart attack than their UK counterparts.
by Gary Finnegan: The European Medicines Agency (EMA) has recommended approval of several new medicines.
by Bruce Sylvester: A study published on Feb. 27, 2014 in The Lancet suggests that amyotrophic lateral sclerosis (ALS) patients who are mildly obese are more likely to… read more.
A new drug treatment has been found to be effective against chronic pain caused by nerve damage, also known as neuropathic pain, in patients who have had shingles.
Hyperactivity of our immune system can cause a state of chronic inflammation. If chronic, the inflammation will affect our body and result in disease. In the devastating disease… read more.
Aging men weighing treatment should be warned about cardiovascular events. According to a statement issued today by the Endocrine Society, the risks and benefits of testosterone therapy for… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
